Human bone marrow mesenchymal stem cell-derived exosomes loaded with gemcitabine inhibit pancreatic cancer cell proliferation by enhancing apoptosis

doi:10.4251/wjgo.v16.i9.4006

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1225)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

HTML

805

Figures (1-3)

Tables (1-1)

109

Sum=1033

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

104

Sum=152

Sep 15, 2024 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 4006-4013
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.4006

Full Size Figure Download Figure

Figure 1 Characterization of mesenchymal stem cell-derived exosomes. A: Transmission electron microscopy analysis of mesenchymal stem cell-derived exosomes; B: Nanoparticle tracking analysis of the size distribution of mesenchymal stem cell-derived exosomes.

Citation: Tang ZG, Chen TM, Lu Y, Wang Z, Wang XC, Kong Y. Human bone marrow mesenchymal stem cell-derived exosomes loaded with gemcitabine inhibit pancreatic cancer cell proliferation by enhancing apoptosis. World J Gastrointest Oncol 2024; 16(9): 4006-4013
URL: https://www.wjgnet.com/1948-5204/full/v16/i9/4006.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.4006